UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs ▲ | Disease Ontology |
---|---|---|---|---|---|
A0A7M4ELE8 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
A0A7M4ESY7 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A7M4EWK9 | Hyaluronidase |
|
1 | 0 |
|
A0A7M4G3N7 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7M4F591 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
2 | 0 |
|
A0A7M4EWM7 | Hyaluronidase |
|
1 | 0 |
|
A0A7M4E7C9 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A7M4F9C6 | Paraoxonase |
|
1 | 0 |
|
A0A7M4F5G7 | P2X purinoceptor |
|
1 | 0 |
|
A0A7M4F554 | Rhodopsin |
|
2 | 0 |
|
A0A7M4EDX2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7M4EXK1 | Hyaluronidase |
|
1 | 0 |
|
A0A7M4FQP2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7M4ECC9 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A7M4FUB2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7M4FCH3 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
A0A7M4ECL7 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A7M4FF51 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7M4ET12 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
A0A7M4DY09 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A7M4DYB6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A7M4FZV9 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
A0A7M4EDG7 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7M4FQA8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A7M4EVE7 | GDNF family receptor alpha-1 |
|
2 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024